Stockreport

PMV Pharmaceuticals Reports Third Quarter 2025 Financial Results and Corporate Highlights

PMV Pharmaceuticals, Inc.  (PMVP) 
PDF Updated clinical results from Phase 2 pivotal portion of the PYNNACLE study evaluating rezatapopt featured in late-breaking oral presentation at the 2025 AACR-NCI-EORTC [Read more]